Eagle Pharmaceuticals (EGRX) Stock Chart & Stock Price History $3.20 0.00 (0.00%) As of 08/12/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Eagle Pharmaceuticals Stock Price Performance The Eagle Pharmaceuticals (EGRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 17.31%, with a year-to-date return of 540.00%. In the past month, the stock has decreased 14.44%, reflecting recent market activity. As of the latest close, Eagle Pharmaceuticals traded at $3.20 with a market cap of $41.56 million and volume of 0 shares. Five years ago, the stock traded at $42.97, representing a 92.55% decrease over that period. At the time, it had a market cap of $604.69 million and a volume of 1,607 shares. Receive EGRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.31%1 Month Performance-14.44%3 Month Performance+64.95%Year-To-Date Performance+540.00%1 Year Performance-17.31%5 Year Performance-92.55% EGRX Stock Chart for Thursday, August, 14, 2025 EGRX Chart by TradingView Eagle Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/12/2025$3.20$3.20$3.20$2.55300 shs$41.56 million08/11/2025$3.19$3.20+0.31%$3.20$2.55300 shs$41.56 million08/08/2025$3.19$3.19$3.19$2.553,769 shs$41.43 million08/07/2025$3.19$3.19$3.19$2.551,413 shs$41.43 million08/06/2025$3.19$3.19$3.19$2.551,413 shs$41.43 million08/04/2025$3.19$3.19$3.19$2.10675 shs$41.43 million08/01/2025$3.69$3.19-13.55%$3.19$2.10675 shs$41.43 million07/25/2025$3.69$3.69$3.69$3.6914 shs$23.38 million07/24/2025$3.69$3.69$3.69$2.50348 shs$47.92 million07/23/2025$3.69$3.69$3.69$2.50348 shs$47.92 million Get the Latest News and Ratings for EGRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/22/2025$3.70$3.69-0.27%$3.69$2.50348 shs$47.92 million07/21/2025$3.70$3.70$3.70$2.501,368 shs$48.05 million07/18/2025$3.69$3.70+0.27%$3.70$2.501,368 shs$48.05 million07/17/2025$3.75$3.69-1.60%$3.69$2.901,332 shs$47.92 million07/16/2025$3.74$3.75+0.27%$3.75$2.601,343 shs$48.70 million07/15/2025$3.74$3.74$3.75$2.607,169 shs$48.57 million07/14/2025$3.55$3.74+5.35%$3.75$2.607,169 shs$48.57 million Related Companies ACRS Stock Price Chart SLS Stock Price Chart CLLS Stock Price Chart VYGR Stock Price Chart DERM Stock Price Chart CTOR Stock Price Chart LFVN Stock Price Chart LIMN Stock Price Chart CTNM Stock Price Chart LXEO Stock Price Chart Receive EGRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EGRX) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGet This Stock NowThis company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardwa...InvestorPlace | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredAmericans are rushing into gold (but not billionaires!)Billionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eagle Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eagle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access